AVAH — Aveanna Healthcare Holdings Income Statement
0.000.00%
- $891.58m
- $2.26bn
- $2.02bn
- 57
- 74
- 88
- 86
Annual income statement for Aveanna Healthcare Holdings, fiscal year end - December 28th, USD millions except per share, conversion factor applied.
2021 January 2nd | 2022 December 31st | 2022 January 1st | 2023 December 30th | 2024 December 28th | |
---|---|---|---|---|---|
Period Length: | 53 W | 52 W | 52 W | 52 W | 52 W |
Source: | PROSPECTUS | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 1,495 | 1,788 | 1,679 | 1,895 | 2,025 |
Cost of Revenue | |||||
Gross Profit | 455 | 553 | 542 | 595 | 636 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,499 | 2,430 | 1,728 | 1,887 | 1,885 |
Operating Profit | -3.56 | -642 | -49.8 | 8.07 | 140 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -51.7 | -664 | -114 | -139 | 5.07 |
Provision for Income Taxes | |||||
Net Income After Taxes | -57 | -662 | -117 | -135 | -10.9 |
Net Income Before Extraordinary Items | |||||
Net Income | -57 | -662 | -117 | -135 | -10.9 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -57 | -662 | -117 | -135 | -10.9 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.009 | -1.03 | 0.009 | -0.353 | -0.004 |
Dividends per Share |